Edition:
United Kingdom

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

0.85USD
15 Feb 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.85
Open
$0.88
Day's High
$0.88
Day's Low
$0.85
Volume
846
Avg. Vol
9,658
52-wk High
$2.04
52-wk Low
$0.53

Latest Key Developments (Source: Significant Developments)

Genetic Technologies Ltd Announces New Biomedical Blockchain Joint Venture
Thursday, 20 Dec 2018 

Dec 20 (Reuters) - Genetic Technologies Ltd ::GENETIC TECHNOLOGIES LTD ANNOUNCES NEW BIOMEDICAL BLOCKCHAIN JOINT VENTURE.GENETIC TECHNOLOGIES LTD - JOINT VENTURE COMPANY, CALLED BLOCKSHINE HEALTH, WILL PURSUE AND DEVELOP BLOCKCHAIN OPPORTUNITIES IN BIOMEDICAL SECTOR.GENETIC TECHNOLOGIES LTD - GTG WILL INVEST $250,000 INTO THE JV AND HAVE A 49% EQUITY STAKE.  Full Article

Genetic Technologies CFO Kevin Fischer Resigns
Tuesday, 20 Nov 2018 

Nov 21 (Reuters) - Genetic Technologies Ltd ::CHIEF FINANCIAL OFFICER KEVIN FISCHER HAS TENDERED HIS RESIGNATION.  Full Article

Genetic Technologies Enters Into A$20 Mln Equity Placement Facility
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - Genetic Technologies Ltd ::ENTERED INTO A A$20 MILLION EQUITY PLACEMENT FACILITY WITH KENTGROVE CAPITAL GROWTH FUND.  Full Article

Genetic Technologies Says Co Entered Framework Agreement With Blockchain Global Limited
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Genetic Technologies Ltd ::CO ENTERED FRAMEWORK AGREEMENT WITH BLOCKCHAIN GLOBAL LIMITED.  Full Article

Genetic Technologies Enters Distribution Deal With Swisstec Health Analytics Ltd
Monday, 30 Jul 2018 

July 30 (Reuters) - Genetic Technologies Ltd ::ENTERS DISTRIBUTION DEAL WITH SWISSTEC HEALTH ANALYTICS LTD.IN EXCHANGE FOR ASIA SCREENING TESTS RIGHTS IN HOSPITALS, CO TO BUY 5 PERCENT STAKE IN SWISSTEC.  Full Article

Genetic Technologies Entered Heads Of Agreement With Swisstec Health Analytics Ltd
Tuesday, 19 Jun 2018 

June 19 (Reuters) - Genetic Technologies Ltd ::ENTERED HEADS OF AGREEMENT WITH SWISSTEC HEALTH ANALYTICS LTD TO FINALISE A PROPOSED JV TO ESTABLISH A NEW COMPANY.GTG TO RECEIVE AN EQUITY STAKE IN SWISSTEC OF UP TO 20%.  Full Article

Genetic Technologies Appointed Paul A. Kasian As Chairman
Monday, 5 Feb 2018 

Feb 5 (Reuters) - Genetic Technologies Ltd ::APPOINTED PAUL A. KASIAN AS CHAIRMAN.MALCOLM. R BRANDON RESIGNS AS CHAIRMAN.  Full Article

  • Previous
  • Next

Genetic Technologies Ltd News

» More GENE.OQ News

Earnings vs. Estimates

» More Financials